(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 7.5% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.17%.
Stepan Co's revenue in 2025 is $2,260,395,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2025 to be $53,691,428,560, with the lowest SCL revenue forecast at $52,017,812,000, and the highest SCL revenue forecast at $55,907,839,680. On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $58,508,730,280, with the lowest SCL revenue forecast at $56,722,031,520, and the highest SCL revenue forecast at $60,860,840,040.
In 2027, SCL is forecast to generate $63,574,812,840 in revenue, with the lowest revenue forecast at $61,675,031,880 and the highest revenue forecast at $66,085,237,680.